Inactive disease and remission in childhood-onset systemic lupus erythematosus.

Rina Mina, Marisa S. Klein-Gitelman, Angelo Ravelli, Michael W. Beresford, Tadej Avcin, Graciela Espada, B. Anne Eberhard, Laura E. Schanberg, Kathleen M. O'Neil, Clovis A. Silva, Gloria C. Higgins, Karen Onel, Nora G. Singer, Emily von Scheven, Lisa F. Imundo, Shannen Nelson, Edward H. Giannini, Hermine I. Brunner

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

To define inactive disease (ID) and clinical remission (CR) and to delineate variables that can be used to measure ID/CR in childhood-onset systemic lupus erythematosus (cSLE). Delphi questionnaires were sent to an international group of pediatric rheumatologists. Respondents provided information about variables to be used in future algorithms to measure ID/CR. The usefulness of these variables was assessed in 35 children with ID and 31 children with minimally active lupus (MAL). While ID reflects cSLE status at a specific point in time, CR requires the presence of ID for >6 months and considers treatment. There was consensus that patients in ID/CR can have 0.85). Disease activity scores with or without the physician global assessment of disease activity and patient symptoms were well suited to differentiate children with ID from those with MAL. Consensus has been reached on common definitions of ID/CR with cSLE and relevant patient characteristics with ID/CR. Further studies must assess the usefulness of the data-driven candidate criteria for ID in cSLE.

Original languageEnglish
Pages (from-to)683-693
Number of pages11
JournalArthritis Care and Research
Volume64
Issue number5
Publication statusPublished - May 2012

Fingerprint

Systemic Lupus Erythematosus
Pediatrics
Physicians

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mina, R., Klein-Gitelman, M. S., Ravelli, A., Beresford, M. W., Avcin, T., Espada, G., ... Brunner, H. I. (2012). Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care and Research, 64(5), 683-693.

Inactive disease and remission in childhood-onset systemic lupus erythematosus. / Mina, Rina; Klein-Gitelman, Marisa S.; Ravelli, Angelo; Beresford, Michael W.; Avcin, Tadej; Espada, Graciela; Eberhard, B. Anne; Schanberg, Laura E.; O'Neil, Kathleen M.; Silva, Clovis A.; Higgins, Gloria C.; Onel, Karen; Singer, Nora G.; von Scheven, Emily; Imundo, Lisa F.; Nelson, Shannen; Giannini, Edward H.; Brunner, Hermine I.

In: Arthritis Care and Research, Vol. 64, No. 5, 05.2012, p. 683-693.

Research output: Contribution to journalArticle

Mina, R, Klein-Gitelman, MS, Ravelli, A, Beresford, MW, Avcin, T, Espada, G, Eberhard, BA, Schanberg, LE, O'Neil, KM, Silva, CA, Higgins, GC, Onel, K, Singer, NG, von Scheven, E, Imundo, LF, Nelson, S, Giannini, EH & Brunner, HI 2012, 'Inactive disease and remission in childhood-onset systemic lupus erythematosus.', Arthritis Care and Research, vol. 64, no. 5, pp. 683-693.
Mina R, Klein-Gitelman MS, Ravelli A, Beresford MW, Avcin T, Espada G et al. Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis Care and Research. 2012 May;64(5):683-693.
Mina, Rina ; Klein-Gitelman, Marisa S. ; Ravelli, Angelo ; Beresford, Michael W. ; Avcin, Tadej ; Espada, Graciela ; Eberhard, B. Anne ; Schanberg, Laura E. ; O'Neil, Kathleen M. ; Silva, Clovis A. ; Higgins, Gloria C. ; Onel, Karen ; Singer, Nora G. ; von Scheven, Emily ; Imundo, Lisa F. ; Nelson, Shannen ; Giannini, Edward H. ; Brunner, Hermine I. / Inactive disease and remission in childhood-onset systemic lupus erythematosus. In: Arthritis Care and Research. 2012 ; Vol. 64, No. 5. pp. 683-693.
@article{b91bbe21fe614b74be80e23a56b44d39,
title = "Inactive disease and remission in childhood-onset systemic lupus erythematosus.",
abstract = "To define inactive disease (ID) and clinical remission (CR) and to delineate variables that can be used to measure ID/CR in childhood-onset systemic lupus erythematosus (cSLE). Delphi questionnaires were sent to an international group of pediatric rheumatologists. Respondents provided information about variables to be used in future algorithms to measure ID/CR. The usefulness of these variables was assessed in 35 children with ID and 31 children with minimally active lupus (MAL). While ID reflects cSLE status at a specific point in time, CR requires the presence of ID for >6 months and considers treatment. There was consensus that patients in ID/CR can have 0.85). Disease activity scores with or without the physician global assessment of disease activity and patient symptoms were well suited to differentiate children with ID from those with MAL. Consensus has been reached on common definitions of ID/CR with cSLE and relevant patient characteristics with ID/CR. Further studies must assess the usefulness of the data-driven candidate criteria for ID in cSLE.",
author = "Rina Mina and Klein-Gitelman, {Marisa S.} and Angelo Ravelli and Beresford, {Michael W.} and Tadej Avcin and Graciela Espada and Eberhard, {B. Anne} and Schanberg, {Laura E.} and O'Neil, {Kathleen M.} and Silva, {Clovis A.} and Higgins, {Gloria C.} and Karen Onel and Singer, {Nora G.} and {von Scheven}, Emily and Imundo, {Lisa F.} and Shannen Nelson and Giannini, {Edward H.} and Brunner, {Hermine I.}",
year = "2012",
month = "5",
language = "English",
volume = "64",
pages = "683--693",
journal = "Arthritis care and research : the official journal of the Arthritis Health Professions Association",
issn = "0893-7524",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Inactive disease and remission in childhood-onset systemic lupus erythematosus.

AU - Mina, Rina

AU - Klein-Gitelman, Marisa S.

AU - Ravelli, Angelo

AU - Beresford, Michael W.

AU - Avcin, Tadej

AU - Espada, Graciela

AU - Eberhard, B. Anne

AU - Schanberg, Laura E.

AU - O'Neil, Kathleen M.

AU - Silva, Clovis A.

AU - Higgins, Gloria C.

AU - Onel, Karen

AU - Singer, Nora G.

AU - von Scheven, Emily

AU - Imundo, Lisa F.

AU - Nelson, Shannen

AU - Giannini, Edward H.

AU - Brunner, Hermine I.

PY - 2012/5

Y1 - 2012/5

N2 - To define inactive disease (ID) and clinical remission (CR) and to delineate variables that can be used to measure ID/CR in childhood-onset systemic lupus erythematosus (cSLE). Delphi questionnaires were sent to an international group of pediatric rheumatologists. Respondents provided information about variables to be used in future algorithms to measure ID/CR. The usefulness of these variables was assessed in 35 children with ID and 31 children with minimally active lupus (MAL). While ID reflects cSLE status at a specific point in time, CR requires the presence of ID for >6 months and considers treatment. There was consensus that patients in ID/CR can have 0.85). Disease activity scores with or without the physician global assessment of disease activity and patient symptoms were well suited to differentiate children with ID from those with MAL. Consensus has been reached on common definitions of ID/CR with cSLE and relevant patient characteristics with ID/CR. Further studies must assess the usefulness of the data-driven candidate criteria for ID in cSLE.

AB - To define inactive disease (ID) and clinical remission (CR) and to delineate variables that can be used to measure ID/CR in childhood-onset systemic lupus erythematosus (cSLE). Delphi questionnaires were sent to an international group of pediatric rheumatologists. Respondents provided information about variables to be used in future algorithms to measure ID/CR. The usefulness of these variables was assessed in 35 children with ID and 31 children with minimally active lupus (MAL). While ID reflects cSLE status at a specific point in time, CR requires the presence of ID for >6 months and considers treatment. There was consensus that patients in ID/CR can have 0.85). Disease activity scores with or without the physician global assessment of disease activity and patient symptoms were well suited to differentiate children with ID from those with MAL. Consensus has been reached on common definitions of ID/CR with cSLE and relevant patient characteristics with ID/CR. Further studies must assess the usefulness of the data-driven candidate criteria for ID in cSLE.

UR - http://www.scopus.com/inward/record.url?scp=84861112450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861112450&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 683

EP - 693

JO - Arthritis care and research : the official journal of the Arthritis Health Professions Association

JF - Arthritis care and research : the official journal of the Arthritis Health Professions Association

SN - 0893-7524

IS - 5

ER -